Abstract 261: Foxo4 Promotes Early Inflammatory Response Upon Myocardial Infarction via Endothelial Arg1
暂无分享,去创建一个
Joseph A. Hill | J. Schneider | S. Morris | S. Goetsch | Zhi-Ping Liu | Min Zhu | Zhaoning Wang | R. Luo | Zhi-ping Liu | Zhi Ping Liu
[1] N. Frangogiannis. Inflammation in cardiac injury, repair and regeneration , 2015, Current opinion in cardiology.
[2] A. Shatanawi,et al. Angiotensin II-Induced Arterial Thickening, Fibrosis and Stiffening Involves Elevated Arginase Function , 2015, PloS one.
[3] R. Schulz,et al. Arginase induction and activation during ischemia and reperfusion and functional consequences for the heart , 2015, Front. Physiol..
[4] Christoph D. Rau,et al. Mapping Genetic Contributions to Cardiac Pathology Induced by Beta-Adrenergic Stimulation in Mice , 2015, Circulation. Cardiovascular genetics.
[5] C. Mineo,et al. Genetic variants of ApoE and ApoER2 differentially modulate endothelial function , 2014, Proceedings of the National Academy of Sciences.
[6] J. Pernow,et al. Effect of Arginase Inhibition on Ischemia-Reperfusion Injury in Patients with Coronary Artery Disease with and without Diabetes Mellitus , 2014, PloS one.
[7] D. Brenner,et al. Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis. , 2014, The Journal of clinical investigation.
[8] N. Sethy,et al. Hypobaric hypoxia induced arginase expression limits nitric oxide availability and signaling in rodent heart. , 2014, Biochimica et biophysica acta.
[9] J. Pernow,et al. Arginase as a target for treatment of myocardial ischemia-reperfusion injury. , 2013, European journal of pharmacology.
[10] S. Morris,et al. Shaping the Murine Macrophage Phenotype: IL-4 and Cyclic AMP Synergistically Activate the Arginase I Promoter , 2013, The Journal of Immunology.
[11] N. Frangogiannis,et al. Targeting inflammatory pathways in myocardial infarction , 2013, European journal of clinical investigation.
[12] J. Lundberg,et al. Arginase regulates red blood cell nitric oxide synthase and export of cardioprotective nitric oxide bioactivity , 2013, Proceedings of the National Academy of Sciences.
[13] C. Jung,et al. Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal? , 2013, Cardiovascular research.
[14] C. Jung,et al. Arginase inhibition improves coronary microvascular function and reduces infarct size following ischaemia–reperfusion in a rat model , 2013, Acta physiologica.
[15] P. Doevendans,et al. Cardiac stem cell therapy to modulate inflammation upon myocardial infarction. , 2013, Biochimica et biophysica acta.
[16] J. Liao. Linking endothelial dysfunction with endothelial cell activation. , 2013, Journal of Clinical Investigation.
[17] A. Eijkelenboom,et al. FOXOs: signalling integrators for homeostasis maintenance , 2013, Nature reviews. Molecular cell biology.
[18] C. Jung,et al. Arginase Inhibition Improves Endothelial Function in Patients With Coronary Artery Disease and Type 2 Diabetes Mellitus , 2012, Circulation.
[19] M. Iruela-Arispe,et al. Trophoblasts regulate the placental hematopoietic niche through PDGF-B signaling. , 2012, Developmental cell.
[20] S. Morris. Arginases and arginine deficiency syndromes , 2012, Current opinion in clinical nutrition and metabolic care.
[21] Qing-Jun Zhang,et al. FoxO4 inhibits atherosclerosis through its function in bone marrow derived cells. , 2011, Atherosclerosis.
[22] F. Gurdol,et al. Serum levels of arginase I are associated with left ventricular function after myocardial infarction. , 2011, Clinical biochemistry.
[23] R. DePinho,et al. FoxO Transcription Factors Promote Cardiomyocyte Survival upon Induction of Oxidative Stress* , 2010, The Journal of Biological Chemistry.
[24] G. Faggian,et al. Dual modulation of nitric oxide production in the heart during ischaemia/reperfusion injury and inflammation , 2010, Thrombosis and Haemostasis.
[25] Allan R. Jones,et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain , 2009, Nature Neuroscience.
[26] M. Feki,et al. Association of rs2781666 G/T polymorphism of arginase I gene with myocardial infarction in Tunisian male population. , 2010, Clinical biochemistry.
[27] Christian Jung,et al. Arginase inhibition mediates cardioprotection during ischaemia-reperfusion. , 2010, Cardiovascular research.
[28] R. Kloner,et al. Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities , 2010, Heart Failure Reviews.
[29] S. Neubauer,et al. Refined approach for quantification of in vivo ischemia-reperfusion injury in the mouse heart , 2009, American journal of physiology. Heart and circulatory physiology.
[30] R. DePinho,et al. FoxO4 inhibits NF-kappaB and protects mice against colonic injury and inflammation. , 2009, Gastroenterology.
[31] S. Morris,et al. Recent advances in arginine metabolism: roles and regulation of the arginases. , 2009, British journal of pharmacology.
[32] M. Daemen,et al. Mouse strain determines the outcome of wound healing after myocardial infarction. , 2009, Cardiovascular research.
[33] Jing Chen,et al. ToppGene Suite for gene list enrichment analysis and candidate gene prioritization , 2009, Nucleic Acids Res..
[34] M. Gladwin,et al. Nitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disorders. , 2008, Current molecular medicine.
[35] K. Chatila,et al. Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling. , 2008, The American journal of pathology.
[36] A. Meixner,et al. S-nitrosylation of microtubule-associated protein 1B mediates nitric-oxide-induced axon retraction , 2007, Nature Cell Biology.
[37] Randall J. Lee,et al. Myocardial infarct size measurement in the mouse chronic infarction model: comparison of area- and length-based approaches. , 2007, Journal of applied physiology.
[38] R. DePinho,et al. FoxO4 Regulates Tumor Necrosis Factor Alpha-Directed Smooth Muscle Cell Migration by Activating Matrix Metalloproteinase 9 Gene Transcription , 2007, Molecular and Cellular Biology.
[39] P J de Feyter,et al. Reduction in infarct size, but no functional improvement after bone marrow cell administration in a porcine model of reperfused myocardial infarction. , 2006, European heart journal.
[40] Wei He,et al. A FoxO–Smad synexpression group in human keratinocytes , 2006, Proceedings of the National Academy of Sciences.
[41] E. Olson,et al. Phenotypic modulation of smooth muscle cells through interaction of Foxo4 and myocardin. , 2005, Developmental cell.
[42] S. Morris,et al. Induction of arginase I transcription by IL-4 requires a composite DNA response element for STAT6 and C/EBPbeta. , 2005, Gene.
[43] B. Rollins,et al. CCL2/Monocyte Chemoattractant Protein-1 Regulates Inflammatory Responses Critical to Healing Myocardial Infarcts , 2005, Circulation research.
[44] Chaoxia He,et al. Hypoxia/reoxygenation stimulates Ca2+-dependent ICAM-1 mRNA expression in human aortic endothelial cells. , 2004, Biochemical and biophysical research communications.
[45] J. Epstein,et al. Tie2-Cre–Induced Inactivation of a Conditional Mutant Nf1 Allele in Mouse Results in a Myeloproliferative Disorder that Models Juvenile Myelomonocytic Leukemia , 2004, Pediatric Research.
[46] A. Dinopoulos,et al. Neutrophil depletion reduces myocardial reperfusion morbidity. , 2004, The Annals of thoracic surgery.
[47] Mario Huerta,et al. Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN , 2003, Nucleic Acids Res..
[48] R. Hammer,et al. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. , 2001, Developmental biology.
[49] S. Morris,et al. Differential regulation of arginases and inducible nitric oxide synthase in murine macrophage cells. , 1998, American journal of physiology. Endocrinology and metabolism.
[50] L. Becker,et al. Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia. Evidence for neutrophil-mediated reperfusion injury. , 1989, Circulation.
[51] M. Schork,et al. Reduction of the Extent of Ischemic Myocardial Injury by Neutrophil Depletion in the Dog , 1983, Circulation.
[52] R Roberts,et al. Deleterious effects of methylprednisolone in patients with myocardial infarction. , 1976, Circulation.
[53] S. Goldstein. Letter: Pacing the WPW patient. , 1976, Circulation.